Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population ; volume:12 ; number:1 ; day:5 ; month:1 ; year:2012 ; pages:1-9 ; date:12.2012
BMC gastroenterology ; 12, Heft 1 (5.1.2012), 1-9, 12.2012
- Beteiligte Personen und Organisationen
-
Sumida, Yoshio
Yoneda, Masato
Hyogo, Hideyuki
Itoh, Yoshito
Ono, Masafumi
Fujii, Hideki
Eguchi, Yuichiro
Suzuki, Yasuaki
Aoki, Noriaki
Kanemasa, Kazuyuki
Fujita, Koji
Chayama, Kazuaki
Saibara, Toshiji
Kawada, Norifumi
Fujimoto, Kazuma
Kohgo, Yutaka
Yoshikawa, Toshikazu
Okanoue, Takeshi
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-12-2
- URN
-
urn:nbn:de:1111-201607156750
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sumida, Yoshio
- Yoneda, Masato
- Hyogo, Hideyuki
- Itoh, Yoshito
- Ono, Masafumi
- Fujii, Hideki
- Eguchi, Yuichiro
- Suzuki, Yasuaki
- Aoki, Noriaki
- Kanemasa, Kazuyuki
- Fujita, Koji
- Chayama, Kazuaki
- Saibara, Toshiji
- Kawada, Norifumi
- Fujimoto, Kazuma
- Kohgo, Yutaka
- Yoshikawa, Toshikazu
- Okanoue, Takeshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Artificial intelligence in nonalcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota